The possibility of confounding by indication should also be considered, as patients prescribed GLP-1RAs may have more severe metabolic disease or different risk profiles than those managed with other approaches
With commercial insurance, copays may be as low as $25 per month through the manufacturer's savings program
As diabetes drugs continue to evolve, clinicians must stay informed about emerging therapies, expanded indications, and safety considerations to optimize patient outcomes
We monitor labs, hormonal markers, and clinical symptoms along the way to ensure were optimizingnot overwhelmingthe body
GLP-1 medications, like Ozempic, Wegovy, and Mounjaro, have various known side effects, including nausea, fatigue, constipation, and diarrhea
It may also cause gastrointestinal side effects